GRI Bio Investor Relations Material
Latest events
Q2 2025
14 Aug, 2025
Corporate Presentation
6 Jul, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from GRI Bio Inc
Access all reports
GRI Bio Inc. is a biotechnology company focused on developing therapies for inflammatory, fibrotic, and autoimmune diseases. The company specializes in modulating natural killer T (NKT) cells to target immune system dysregulation. Its research and development efforts aim to advance novel small-molecule drug candidates for conditions with high unmet medical needs. The company is headquartered in La Jolla, California, and its shares are listed on the NASDAQ.
Key slides for GRI Bio Inc
Corporate Presentation
GRI Bio Inc
Corporate Presentation
GRI Bio Inc
Latest articles
)
The Dilemma That Brought Down Kodak
Kodak helped invent digital photography but failed to embrace it. How the innovator's dilemma turned an icon into its own most famous casualty.
21 Aug 2025
)
Maziar Mike Doustdar: Novo Nordisk's New CEO
A portrait of the pharmaceutical giant's new CEO, who assumes the position at a critical time for the company in its competition with Eli Lilly.
12 Aug 2025
)
Novo Nordisk: Tipping the Scale of Innovation
Taking a look at the company behind Ozempic and Wegovy and diving into their history, business, and the challenges it now faces
8 Aug 2025
Ticker symbol
GRI
Country
🇺🇸 United States